Duke is one of only a handful of major specialty care facilities in the U.S. to emphasize comprehensive treatment of adults with congenital cardiac disease.

The group specializes in advanced treatment methods, including the use of catheter-based devices and minimally invasive surgery.

The adult congenital heart disease service is part of the Duke Division of Cardiology, the Duke Division of Pediatric Cardiology, and the Duke Heart Center.

Duke Heart Services

• Over 700 faculty and staff members with over 100 board-certified cardiologists, cardiac surgeons, and cardiac anesthesiologists
• One of the world’s leading cardiovascular clinical research programs, including the Duke Clinical Research Institute and Duke Databank for Cardiovascular Disease -- the largest and oldest database of coronary artery disease outcomes
• Serving as the analytic engine for the American College of Cardiology’s National Cardiovascular Data Registry, the Society of Thoracic Surgeons’s National Database, the CRUSADE National Quality Improvement Initiative, and the American Heart Association’s Get with the Guidelines initiative
• Top congestive heart failure program in the country (based on volume, NIH and private funding, and publications)
• First and longest-running post-CABG cardiac rehabilitation practice in the country
• Largest cardiovascular MRI program in the world (based on clinical volume and research funding)
• Largest cardiac transplant, congestive heart failure, adult valvular, and congenital heart disease programs in the Southeast
• Consistently ranked among the top heart programs in the nation by U.S.News & World Report
• Home to major breakthroughs in cardiovascular care, including the first perfusion balloon angioplasty catheter, first realtime volumetric ultrasound system for 3-D heart imaging, and introduction of the bioabsorbable coronary stent